Condensed pyrazole derivatives with interleukin-1 and tumour necrosis factor inhibitory activity
申请人:FUJISAWA PHARMACEUTICAL CO., LTD.
公开号:EP0531901A2
公开(公告)日:1993-03-17
1. A compound of the formula :
wherein
R¹ isaryl which may have suitable substituent(s) or heterocyclic group which may have suitable substituent(s),
R² isaryl which may have suitable substituent(s) or heterocyclic group which may have suitable substituent(s), and
Y isa bivalent radical selected from
(in which ---- means single bond or double bond), each of which may have suitable substituent(s), and
pharmaceutically acceptable salts thereof, processes for their preparation and pharmaceutical compositions comprising them.
1.式中的化合物:
式中
R¹为芳基,可具有合适的取代基,或为杂环基,可具有合适的取代基、
R² 是芳基,可带有合适的取代基或杂环基,可带有合适的取代基,以及
Y 是二价基,选自
(其中 ---- 指单键或双键),其中每个基团可具有合适的取代基,以及
它们的药学上可接受的盐、其制备工艺和包含它们的药物组合物。